MDL For 84 Onglyza Diabetes Drug Cases Sent To Kentucky Federal Court

(February 5, 2018, 12:12 PM EST) -- WASHINGTON, D.C. — A federal judicial panel on Feb. 2 centralized 84 federal lawsuits alleging that the diabetes drug Onglyza and a related combination drug cause heart failure and other injuries (In Re:  Onglyza and Kombiglyze XR Products Liability Litigation, MDL Docket No. 2809, JPMDL, 2018 U.S. Dist. LEXIS 17208)....

Attached Documents

Related Sections